As the Trump administration takes aim at rising drug costs, organizations from across the healthcare industry are weighing in on proposals from its blueprint to address the issue.
Industry groups weigh in on HHS’ drug price blueprint
As the Trump administration takes aim at rising drug costs, organizations from across the healthcare industry are weighing in on proposals from its blueprint to address the issue.